Molina Investors Urged to Seek Lead Plaintiff Role by Dec. 2 in Securities Suit Over Cost Trend Disclosures

Overview

• Multiple shareholder firms, including Wolf Haldenstein, The Schall Law Firm, and DJS Law Group, issued new notices on Nov. 10–11 inviting motions for lead-plaintiff appointment by Dec. 2, 2025.
• The complaint alleges violations of Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5 tied to purportedly false statements about medical cost trends and the company’s financial outlook.
• The putative class covers purchases of Molina Healthcare securities from Feb. 5, 2025 through July 23, 2025.
• Molina cut 2025 guidance on July 7 after weaker Q2 adjusted EPS and reduced it again on July 23, after which shares fell nearly 17 percent.
• The class has not been certified, so investors remain unrepresented unless they move to serve as lead plaintiff.